Soho Flordis International (SFI) is a global natural medicine company committed to identifying and developing leading natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

SFI is focused on bringing its products to market through healthcare professionals with the endorsement of world class opinion leaders.


SFI is committed to ensuring that people globally have access to quality, innovative evidence based natural medicines. Therefore it is our aim that the safety and efficacy claims for our products are supported by specific clinical evidence. This higher standard enables the selection of safe, appropriate and effective treatments.
View our brands here.


SFI is building an international community of leading herbal and medical companies, experts, scientists and researchers.
View our partners here.


We are committed to further developing the evidence for our products.
View our research programs here.

latest news

SFI Korea impresses at BioKorea 2016

Tuesday, April 12, 2016 - 09:30
SFI Korea exhibited the SFI Group product portfolio at this year’s BioKorea 2016 in Seoul, impressing many key industry and government stakeholders at the event.

SFI Research clinical trial receives strong recruitment boost

Tuesday, March 22, 2016 - 16:10
SFI Research’s clinical trial with the Boden Institute at the University of Sydney received a strong recruitment boost, when the trial and the dietary supplements being investigated were covered by Australia’s Channel NINE News.

Gincosan® and Songha® Night launched in Korea

Wednesday, February 10, 2016 - 14:07
Soho Flordis International (SFI) is proud to announce the launch of Gincosan® and Songha® Night in Korea in December 2015, together with its local partner Pharvis Cooperation Korea. Pharvis is one of Korea’s leading healthcare companies, selling a range of pharmaceutical products and Health Functional Foods, mainly in the gastrointestinal area.

Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen™ brand portfolio from Vifor Pharma

Friday, October 23, 2015 - 10:19
Soho Flordis International (SFI), through its Swiss subsidiary company Ginsana SA, will acquire leading UK manufacturer and supplier of traditional herbal treatments Potters, from Vifor Pharma, a company of the Galenica Group.